Innovation Theaters

July 15-17, 2021 - Eastern Time


Title: Study Results from First and Only Randomized Pivotal Trial in R/R DLBCL
Speaker: Charles Farber, MD
Thursday, July 15 at 10:45 AM
Presented by:


Title: An Overview of CLL and the Use of a Targeted Agent For Previously Untreated or R/R CLL
Speaker: Mihir Raval, MD
Thursday, July 15 at 1:50 PM
Presented by:


Title: ICLUSIG®(ponatinib): Taking Action At The Critical Moment
Speaker: Jonathan Abbas, MD
Thursday, July 15 at 4:55 PM
Presented by:


Title: Stand Strong Against Platelet Destruction With TAVALISSE: A Patient’s ITP Treatment Journey
Speaker: Richard McDonough, MD
Friday, July 16 at 8:00 AM
Presented by:


Title: A Treatment Option for Patients With Myelofibrosis
Speaker: Ralph V. Boccia, MD, FACP
Friday, July 16 at 11:05 AM
Presented by:


Title: A Case-based Presentation on Improving Outcomes in Patients With Newly-Diagnosed Secondary AML
Speaker: Maher Abdul Hay, MD
Friday, July 16 at 1:50 PM
Presented by:


Title: A New Treatment Option for Adults With Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy
Speaker: Nilanjan Ghosh, MD
Saturday, July 17 at 11:05 AM
Presented by:


Title: NINLARO® (ixazomib): Durable Strength When Navigating the Difficulties of Multiple Myeloma in the Real World
Speaker: Suzanne Fanning, DO
Saturday, July 17 at 2:10 PM
Presented by: